benzyl isothiocyanate has been researched along with Osteosarcoma in 1 studies
benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, CL | 1 |
| Huang, AC | 1 |
| Yang, JS | 1 |
| Liao, CL | 1 |
| Lu, HF | 1 |
| Chou, ST | 1 |
| Ma, CY | 1 |
| Hsia, TC | 1 |
| Ko, YC | 1 |
| Chung, JG | 1 |
1 other study available for benzyl isothiocyanate and Osteosarcoma
| Article | Year |
|---|---|
Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic
Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; DNA Dam | 2011 |